EntryPoint Capital’s Astrana Health ASTH Stock Holding History

EntryPoint Capital’s Portfolio ASTH Stock Details ASTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-13,477	Closed	-$382K	–	880
2025 Q3	$382K	Buy	13,477 +2,319	+21%	+$62.8K	0.15%	260
2025 Q2	$278K	Buy	+11,158	New	+$314K	0.14%	318
2024 Q3	–	Sell	-388	Closed	-$15.7K	–	1218
2024 Q2	$15.7K	Buy	+388	New	+$15.4K	0.02%	732
2024 Q1	–	Sell	-7,031	Closed	-$269K	–	1810
2023 Q4	$269K	Buy	+7,031	New	+$234K	0.26%	35

Other funds holding ASTH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

325 Capital New York $274M AUM 49.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

EntryPoint Capital's ASTH Position: Q4 2025 in Review

EntryPoint Capital sold out of Astrana Health (ASTH) in Q4 2025, closing a stake of 13,477 shares — an estimated $382K sold.

EntryPoint Capital first reported a position in ASTH in Q4 2023 and held it in 4 quarters. The position peaked at $382K in Q3 2025. 175 funds tracked by Wall St. Rank hold ASTH as of Q4 2025.

EntryPoint Capital reported no remaining Astrana Health position as of Q4 2025 after selling out during the quarter.
EntryPoint Capital sold 13,477 Astrana Health shares in Q4 2025, an estimated $382K.
EntryPoint Capital first reported a position in Astrana Health in Q4 2023 and held it in 4 quarters.
EntryPoint Capital's Astrana Health position peaked at $382K in Q3 2025.
175 funds tracked by Wall St. Rank held Astrana Health as of Q4 2025.

Based on EntryPoint Capital's 13F filing for Q4 2025, filed 12 Feb 2026.